0000899243-15-002781.txt : 20150811 0000899243-15-002781.hdr.sgml : 20150811 20150811114014 ACCESSION NUMBER: 0000899243-15-002781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150811 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001631650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452748244 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 BUSINESS PHONE: (650) 614-5220 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 FORMER COMPANY: FORMER CONFORMED NAME: Allergen Research Corp DATE OF NAME CHANGE: 20150123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwicki Mark T CENTRAL INDEX KEY: 0001415537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043026 MAIL ADDRESS: STREET 1: 84 WATERFORD DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-11 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001415537 Iwicki Mark T C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 1 0 0 0 Common Stock, $0.0001 par value 2015-08-11 4 P 0 20000 16.00 A 20000 D Reporting Person purchased 20,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share. /s/ Warren L. DeSouza, as Attorney-in-Fact for Mark T. Iwicki 2015-08-11